LVAD/心臓移植 心移植で脳死後心臓に心停止後心臓は劣らない:N Engl J Med. 2023 Jun 8;388(23):2121-2131. Transplantation Outcomes with Donor Hearts after Circulatory Death Jacob N Schroder, et al. N Engl J Med. 2023 Jun 8;388... 2024.01.28 LVAD/心臓移植
CPB CPB使用心臓手術中のALBは細胞外液と予後の差は生じない:JAMA. 2022 Jul 19;328(3):251-258. Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Card... 2024.01.22 CPB
CPB 術中ALBの心筋に対する有用性:J Cardiothorac Vasc Anesth. 2024 Jan;38 (1):86-92. Albumin and Cardioprotection in On- Pump Cardiac Surgery-A Post Hoc Analysis of a Randomized Trial Hanna Vlasov, et al. ... 2024.01.19 CPB
LVAD/心臓移植 PROCEEDⅡ Trial(ドナー心はOCSと低温保存でどちらが優れるか?):Lancet. 2015 Jun 27;385(9987):2577-84. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, ... 2024.01.16 LVAD/心臓移植
LVAD/心臓移植 Organ Care Systemの是非:J Cardiothorac Surg. 2020 Oct 27;15(1):323. Heart transplantation of patients with ventricular assist devices: impact of normothermic ex-vivo preservation using org... 2024.01.12 LVAD/心臓移植
LVAD/心臓移植 心臓移植にOCSは何をもたらした?:Cureus. 2022 Jun 24;14(6):e26281. Is the Organ Care System (OCS) Still the First Choice With Emerging New Strategies for Donation After Circulatory Death ... 2024.01.09 LVAD/心臓移植
免疫 心臓周術期のNLR:J Cardiothorac Vasc Anesth. 2022 May;36(5):1296-1303. Perioperative Neutrophil-Lymphocyte Ratio Predicts Mortality After Cardiac Surgery: Systematic Review and Meta-Analysis ... 2024.01.07 免疫
レミマゾラム PONV効果における効果におけるレミマゾラムとプロポフォールの比較:J Clin Med. 2023 Aug 20;12(16):5402. Remimazolam's Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecolog... 2024.01.03 レミマゾラム